AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2008
Jul 15, 2008
35134_dirs_2008-07-15_df178776-fcd1-4435-a1f8-6be929ed7221.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2008-06-17
Reporting Person: Jensen Development CO (Director, Former President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-06-17 | Croff Enterprises Common Stock | S | 128358 | $1.12 | Disposed | 0 | Direct |
| 2008-06-21 | Croff Enterprises Common Stock | S | 50344 | $1.82 | Disposed | 0 | Direct |
| 2008-06-21 | Croff Enterprises Common Stock | S | 50343 | $1.82 | Disposed | 0 | Direct |
| 2008-06-21 | Croff Enterprises Common Stock | S | 29923 | $1.82 | Disposed | 0 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16